UVA Lab Research Becomes FDA-Approved Leukemia Drug

A husband-and-wife research team turned their midnight lab conversations at the University of Virginia into ziftomenib, a newly FDA-approved drug now saving lives of leukemia patients who had run out of options.

Their 17-year journey from academic research to life-saving treatment shows how university labs can tackle diseases others overlook.